Chinese Clinical Oncology

• 综述与讲座 • Previous Articles     Next Articles

Research progress of cardiotoxicity induced by anti-tumor treatment

LI Chen,SUN Libin,QIU Wensheng   

  1. The Second Department of Oncology,Affiliated Hospital of Qingdao University,Qingdao 266003,China
  • Received:2016-08-25 Revised:2016-10-22 Online:2016-12-31 Published:2016-12-31
  • Contact: QIU Wensheng

Abstract: Malignant tumor is one of the main causes of death in society at present. The survival rate of cancer patients is significantly improved by modern anti-tumor treatment. For the long living of cancer patients,the incidence of cardiovascular adverse events is significant increased with the development of anti-tumor treatment,and cardiologists pay more attention on it. The main cardiac toxicity induced by anti-tumor therapy includs left ventricular systolic dysfunction,heart failure,hypertension, pericardial disease,arrhythmia,thrombosis,atrial fibrillation and etc. Cardiologists have developed therapeutic strategies and optimization methods to prevent and detect cardiac toxicity in the process of anti-tumor treatment in order to improve the living quality of cancer patients. The common cardiac toxicity caused by anti-tumor treatment will be discussed in this review.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!